Holen Sie sich die Stockscreener-App
14.93
0.40%
0.06
Handel nachbörslich:
14.91
-0.02
-0.13%
Schlusskurs vom Vortag:
$14.87
Offen:
$14.91
24-Stunden-Volumen:
103.50K
Relative Volume:
0.61
Marktkapitalisierung:
$1.00B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-46.13M
KGV:
-18.38
EPS:
-0.8123
Netto-Cashflow:
$-34.10M
1W Leistung:
-1.13%
1M Leistung:
-2.48%
6M Leistung:
-17.60%
1J Leistung:
-15.70%
1-Tages-Spanne:
$14.51
$14.96
1-Wochen-Bereich:
$14.51
$15.38
52-Wochen-Spanne:
$13.50
$25.00
Pulse Biosciences Inc Stock (PLSE) Company Profile
Firmenname
Pulse Biosciences Inc
Sektor
Telefon
510-906-4600
Adresse
3957 POINT EDEN WAY, HAYWARD, CA
Vergleichen Sie PLSE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
14.93 | 1.00B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
495.86 | 175.16B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
185.32 | 52.63B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
91.86 | 45.46B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
275.16 | 40.10B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
263.51 | 20.05B | 2.90B | 467.20M | 306.90M | 6.37 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Eingeleitet | Oppenheimer | Outperform |
| 2021-07-27 | Eingeleitet | Stephens | Overweight |
| 2021-03-11 | Eingeleitet | Maxim Group | Buy |
| 2021-01-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-12 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Pulse Biosciences Inc Aktie (PLSE) Neueste Nachrichten
Pulse Biosciences Inc. Stock Analysis and ForecastMarket-crushing profits - PrintWeekIndia
Why Pulse Biosciences Inc. stock attracts strong analyst attentionIntraday Trade Ideas - Newser
Is Pulse Biosciences Inc. a good long term investmentPhenomenal capital appreciation - Autocar Professional
What analysts say about Pulse Biosciences Inc. stockUnmatched profit growth - jammulinksnews.com
What drives Pulse Biosciences Inc. stock priceDynamic portfolio growth - Autocar Professional
Should I buy Pulse Biosciences Inc. stock before earningsFree Deep Market Trend Analysis - Newser
How Pulse Biosciences Inc. stock performs during market volatilityDaily Top Gainers - beatles.ru
Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference - 富途牛牛
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 16, 2025 - BioSpace
Pulse Biosciences Appoints New VP of Accounting - The Globe and Mail
What makes Pulse Biosciences Inc. stock price move sharplyBreakout Momentum Alerts - Newser
Pulse Biosciences appoints Steven T. Weber as principal accounting officer - Investing.com
Don't Ignore The Insider Selling In Pulse Biosciences - 富途牛牛
(PLSE) Proactive Strategies - news.stocktradersdaily.com
Pulse Biosciences stock initiated at Outperform by Oppenheimer on nsPFA potential - Investing.com Canada
Oppenheimer initiates coverage on Pulse Biosciences with an Outperform rating, $22 PT. - AInvest
Oppenheimer & Co. Inc. Sells 5,000 Shares of Pulse Biosciences, Inc (NASDAQ:PLSE) - Defense World
(PLSE) Long Term Investment Analysis - news.stocktradersdaily.com
GAMMA Investing LLC Boosts Stock Position in Pulse Biosciences, Inc (NASDAQ:PLSE) - Defense World
Farther Finance Advisors LLC Has $143,000 Stock Holdings in Pulse Biosciences, Inc (NASDAQ:PLSE) - Defense World
Insider Sell: Darrin Uecker Sells 30,000 Shares of Pulse Bioscie - GuruFocus
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Nuveen Asset Management LLC Has $990,000 Stock Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
BNP Paribas Financial Markets Has $35,000 Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Deutsche Bank AG Boosts Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
5.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):